SOLUTIONS

SOLUTIONS

Eurofins Discovery built its industry-leading reputation on successfully delivering best-in-class drug discovery services to any organization, large or small. No matter where you are in the preclinical process—or if you need full end-to-end solutions—our experts support you every step of the way with purpose, precision, and innovation.
 
As a global leader in drug discovery for over 40 years, we have strategically amassed a deep and broad range of over +10,000 assays for every type of research, as well as a full team of industry experts across disciplines to collaborate with you. Delve into all the ways we can work together by choosing the best path forward for you from our comprehensive services.

Small Molecules
Biotherapeutics
Integrated Drug Discovery
Therapeutic Areas
Research Phase
Custom Solutions

Research Phase

As your partner in the drug discovery process—whether you have specific requirements for one phase, several phases, or even the entire discovery process Eurofins Discovery provides the assays and services needed to reach your program goals. We deliver both the molecules and robust, scalable, and trustworthy data vetted by a thorough Quality Assurance/Quality Control (QA/QC) process.
 
We’ve built our preeminent reputation on our ability to design, synthesize and deliver target molecules while delivering results with integrity, reliability, and strategic guidance. We provide everything from biochemical assays for target identification and biophysical characterization of lead molecules with SPR, to functional and translational assays that provide insights on mechanism-of-action and target modulation in both in vitro and in vivo settings. We also offer opportunities to benchmark against standards-of-care.
 
Beyond our industry-leading off-the-shelf solutions, our premier services include expertise in developing customized assays specifically for your program.

Research Phase image
Key Areas

Discover our innovative approaches to advance understanding of human disease at the molecular level.

Demonstrate target druggability and modulation with screening and early characterization of molecular mechanisms.

Address challenging targets and new modalities through AI-driven and conventional innovative strategies, with agile platforms and a collaborative approach.

Rapidly assess the most promising molecules that demonstrate a true structure-activity relationship (SAR) for further development towards a lead candidate.

Design a rigorous translational study with our drug discovery specialists that have delivered 40+ robust molecules into the clinic.

Confidently select your optimized lead candidate molecules with demonstrated efficacy, safety, and manufacturability leveraging Eurofins Discovery expertise.